z-logo
Premium
Potentially inappropriate medicines in a cohort of community‐dwelling older people in N ew Z ealand
Author(s) -
Nishtala Prasad S,
Bagge Michael L,
Campbell A John,
Tordoff June M
Publication year - 2014
Publication title -
geriatrics and gerontology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 57
eISSN - 1447-0594
pISSN - 1444-1586
DOI - 10.1111/ggi.12059
Subject(s) - medicine , polypharmacy , medical prescription , confidence interval , poisson regression , odds ratio , cohort , pharmacology , population , environmental health
Aim To examine independent factors associated with potentially inappropriate medicines ( PIM ) among 316 community‐dwelling people aged ≥75 years living in D unedin. Methods People aged ≥75 years living in the community in D unedin, N ew Z ealand, taking ≥1 prescription medicines, randomly sampled from the electoral roll, were interviewed about their medicine‐taking practices. A medication inventory comprising prescription and non‐prescription medicines was taken from each participant at the time of the interview. Participants used a median of seven prescription medicines (range 1–19) and one non‐prescription medicine (0–14). PIM were identified using the updated 2012 B eers criteria. Results PIM were identified in 42.7% ( n  = 135) older people. A total of 23 (7.2%) took two PIM , five (1.5%) took three PIM , four (1.2%) took four PIM and one (0.3%) took five PIM . Of the 184 total PIM identified, the top three drug classes were non‐ COX ‐selective non‐steroidal anti‐inflammatory drugs (24.0%), tricyclic antidepressants (16.8%) and benzodiazepines (14.6%). Polypharmacy (adjusted odds ratio [ OR ] 2.06, 95% confidence interval [ CI ] 1.03–4.12) and the use of any psychotropic drug use ( OR 22.05, 95% CI 5.80–83.84) were associated with PIM exposure. In the Poisson regression model, the risk of taking a PIM significantly decreased with age ( OR 0.95, CI 0.91–0.99) and increased as the number of drugs prescribed increased ( OR 1.11, CI 1.08–1.15). Conclusion The prevalence of PIM is relatively high in community‐dwelling older people aged ≥75 years living in N ew Z ealand. PIM defined by the B eers criteria might be a useful initial screening tool, before efforts to stop unsafe medication use or replace with safer alternatives are initiated. Geriatr Gerontol Int 2014; 14: 89–93.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom